Randomized Controlled Trial for Assessment of a Novel Non-Pharmacologic Intervention for Decrease in Altitude Illness
The study is examining if an over-the-counter device (Theravent) worn while sleeping can reduce acute mountain sickness upon awakening in a high altitude trekking population.
Stanford is not currently accepting new patients for this trial. You may want to check clinicaltrials.gov to see if other locations are recruiting.
- device : Control
- device : Theravent
Ages Eligible For Study:
- ages 18-65 - Lake Louise Score (LLS) of < 3 - Have not taken NSAIDs, acetazolamide, or corticosteroids in the prior week - Have not traveled above 4200 m in the prior week. - First night in Pheriche or Dingboche